Pulmatrix, Inc. (PULM) shareholders
Close on Nov 17, 2026Market cap $5.00MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RCM Eos PIPE HOLDINGS, LLC Joint filing with Slawin Kevin M. (9.99%), Rapha Capital Management, LLC (9.99%) | 405,358 | 9.99% | 13D (active) | Apr 16, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PULM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 122,698 | 3.36% | $208.59K | +13,550 | 0.00% |
| BlackRock, Inc. | 54,899 | 1.50% | $93.33K | – | 0.00% |
| Geode Capital Management, LLC | 33,299 | 0.91% | $56.63K | −11,330 | 0.00% |
| Vanguard Capital Management LLC | 32,294 | 0.88% | $54.90K | −1,300 | 0.00% |
| SBI Securities Co., Ltd. | 31,285 | 0.86% | $53.19K | +1,200 | 0.00% |
| Shay Capital LLC | 18,857 | 0.52% | $32.06K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 14,715 | 0.40% | $25.02K | – | 0.00% |
| State Street Corp | 13,945 | 0.38% | $23.71K | – | 0.00% |
| XTX Topco Ltd | 11,991 | 0.33% | $20.39K | −1,678 | 0.00% |
| UBS Group AG | 515 | 0.01% | $875 | +492 | 0.00% |
| Barclays PLC | 15 | 0.00% | $26 | New | 0.00% |
| Farther Finance Advisors, LLC | 7 | 0.00% | $12 | – | 0.00% |
| Royal Bank of Canada | 7 | 0.00% | $0 | – | 0.00% |
| Allworth Financial LP | 3 | 0.00% | $6 | – | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | 0.00% | $2 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 15 | 0M | 9.2% | 2 / 3 | 3 / 2 | 0M | 0M |
| Q1 2026 | 15 | 0M | 9.0% | 5 / 2 | 4 / 4 | 0M | 0M |
| Q4 2025 | 15 | 0M | 9.8% | 3 / 1 | 6 / 2 | 0M | 0M |
| Q3 2025 | 14 | 0M | 9.5% | 4 / 3 | 4 / 2 | 0M | 0M |
| Q2 2025 | 12 | 0M | 9.2% | 2 / 7 | 1 / 1 | 0M | 0M |
| Q1 2025 | 11 | 0M | 8.6% | 1 / 4 | 3 / 1 | 0M | 0M |
| Q4 2024 | 11 | 0M | 8.9% | 2 / 2 | 3 / 3 | 0M | 0M |
| Q3 2024 | 12 | 0M | 7.2% | 3 / 3 | 3 / 1 | 0M | 0M |
| Q2 2024 | 11 | 0M | 6.9% | 2 / 2 | 3 / 4 | 0M | 0M |
| Q1 2024 | 13 | 0M | 6.8% | 2 / 3 | 3 / 1 | 0M | 0M |
| Q4 2023 | 12 | 0M | 8.3% | 0 / 6 | 2 / 0 | 0M | 0M |
| Q3 2023 | 12 | 0M | 10.5% | 0 / 7 | 1 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held PULM in Q1 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PULM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 32,294 | 0.88% | $54.90K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 23,014 | 0.63% | $31.99K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,228 | 0.14% | $7.27K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 4,570 | 0.13% | $6.35K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 4,427 | 0.12% | $6.15K | 0.00% | May 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +15,007 | – | – | 67,729 |
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +769,989 | – | – | 3,468,190 |
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +6,478 | – | – | 29,178 |
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +7,700 | – | – | 34,587 |
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +345,551 | – | – | 1,556,676 |
| Polaris Venture Management Co. V, L.L.C. 10% owner | Apr 3, 2018 | Buy | +5,275 | – | – | 23,875 |
| Matthew L. Sherman Director | Apr 3, 2018 | Buy | +20,000 | – | – | 20,000 |
| ARCH Venture Partners VII, L.P. – | Apr 3, 2018 | Buy | +1,150,000 | – | – | 3,436,456 |
| Mark T. Iwicki Director | Apr 3, 2018 | Buy | +307,000 | – | – | 307,000 |
| David L. Hava Chief Scientific Officer | Mar 22, 2017 | Option exercise | +2,263 | $2.21 | $5.00K | 2,263 |
| Robert W. Clarke Chief Executive Officer, Director | Mar 22, 2017 | Option exercise | +4,525 | $2.21 | $10.00K | 4,525 |
| Oculus Innovative Sciences, Inc. 10% owner | Jun 17, 2015 | Sale | −922,500 | $2.75 | $2.54M | 0 |
| Oculus Innovative Sciences, Inc. 10% owner | Jun 16, 2015 | Sale | −727,500 | $2.75 | $2.00M | 922,500 |
| David Maki Director | Jun 16, 2015 | Buy | +36,375 | $6.88 | $250.26K | 218,194 |
| David Maki Director | Jun 16, 2015 | Buy | +36,375 | $6.88 | $250.26K | 218,194 |
| Scott M. Rocklage Director | Jun 16, 2015 | Buy | +33,990 | $6.88 | $233.85K | 1,192,154 |
| Scott M. Rocklage Director | Jun 16, 2015 | Buy | +4,815 | $6.88 | $33.13K | 168,873 |
| Keith Crandell 10% owner | Jun 16, 2015 | Buy | +72,750 | $6.88 | $500.52K | 2,286,456 |
| Polaris Venture Partners V, L.P. 10% owner | Jun 15, 2015 | Buy | +1,392 | $6.88 | $9.58K | 52,722 |
| Polaris Venture Partners V, L.P. 10% owner | Jun 15, 2015 | Buy | +715 | $6.88 | $4.92K | 26,887 |
| Polaris Venture Partners V, L.P. 10% owner | Jun 15, 2015 | Buy | +490 | $6.88 | $3.37K | 18,600 |
| Polaris Venture Partners V, L.P. 10% owner | Jun 15, 2015 | Buy | +71,439 | $6.88 | $491.50K | 2,698,201 |
| David L. Hava Chief Scientific Officer | Jun 15, 2015 | Award | +4,863 | – | – | 4,863 |
| David Maki Director | Jun 15, 2015 | Award | +181,819 | – | – | 181,819 |
| David Maki Director | Jun 15, 2015 | Award | +181,819 | – | – | 181,819 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +1,179,066 | – | – | 1,179,066 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +32,059 | $6.88 | $220.57K | 1,211,125 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +489 | $6.88 | $3.36K | 18,599 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +26,172 | – | – | 26,172 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +1,392 | $6.88 | $9.58K | 52,692 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +18,110 | – | – | 18,110 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +71,438 | $6.88 | $491.49K | 2,698,200 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +2,626,762 | – | – | 2,626,762 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +601 | $6.88 | $4.13K | 22,700 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +22,099 | – | – | 22,099 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Buy | +714 | $6.88 | $4.91K | 26,886 |
| Venture Partners Iv Lp Polaris 10% owner | Jun 15, 2015 | Award | +51,330 | – | – | 51,330 |
| Robert W. Clarke Chief Executive Officer, Director | Jun 15, 2015 | Award | +18,667 | – | – | 18,667 |
| Scott M. Rocklage Director | Jun 15, 2015 | Award | +164,058 | – | – | 164,058 |
| Scott M. Rocklage Director | Jun 15, 2015 | Award | +1,158,164 | – | – | 1,158,164 |
| Keith Crandell 10% owner | Jun 15, 2015 | Award | +2,213,706 | – | – | 2,213,706 |
| Oculus Innovative Sciences, Inc. 10% owner | Mar 23, 2015 | Sale | −350,000 | $2.75 | $962.50K | 1,650,000 |
| Gregory M. French Director | May 11, 2014 | Award | +58,000 | – | – | 58,000 |
| Richard K. Conley Director | May 11, 2014 | Award | +58,000 | – | – | 58,000 |
| Hojabr Alimi CEO and Chief Science Officer, Director | May 11, 2014 | Award | +125,000 | – | – | 125,000 |
| Sameer Harish Chief Financial Officer | May 11, 2014 | Award | +74,600 | – | – | 74,600 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pulmatrix's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?